Advances in MRI assessment of gliomas and response to anti-VEGF therapy
WB Pope, JR Young, BM Ellingson - Current neurology and neuroscience …, 2011 - Springer
Bevacizumab is thought to normalize tumor vasculature and restore the blood–brain barrier,
decreasing enhancement and peritumoral edema. Conventional measurements of tumor …
decreasing enhancement and peritumoral edema. Conventional measurements of tumor …
Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer
Purpose Diffusion-weighted magnetic resonance imaging (DWI) and fluorodeoxyglucose
positron emission tomography/computed tomography (FDG PET/CT) are oncological …
positron emission tomography/computed tomography (FDG PET/CT) are oncological …
Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer
WD Foltz, A Wu, P Chung, C Catton… - Journal of Magnetic …, 2013 - Wiley Online Library
Purpose: To evaluate regional and temporal changes in apparent diffusion coefficient (ADC)
and T2 relaxation during radiation therapy (RT) in patients with low and intermediate risk …
and T2 relaxation during radiation therapy (RT) in patients with low and intermediate risk …
[HTML][HTML] A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer
PURPOSE: In the current study we examined the ability of diffusion MRI (dMRI) to predict
pathologic response in pancreatic cancer patients receiving neoadjuvant chemoradiation …
pathologic response in pancreatic cancer patients receiving neoadjuvant chemoradiation …
[HTML][HTML] Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?
A Afaq, A Andreou, DM Koh - Cancer Imaging, 2010 - ncbi.nlm.nih.gov
Diffusion-weighted magnetic resonance imaging (DWI) is increasingly being used to assess
tumour response to a variety of anticancer treatments. The technique is quick to perform …
tumour response to a variety of anticancer treatments. The technique is quick to perform …
Physiologic and metabolic magnetic resonance imaging in gliomas
Y Cao, PC Sundgren, CI Tsien… - Journal of Clinical …, 2006 - ascopubs.org
Magnetic resonance (MR) imaging provides excellent soft tissue differentiation and in vivo
assessment of physiologic and metabolic properties of tissue. As new and more aggressive …
assessment of physiologic and metabolic properties of tissue. As new and more aggressive …
Differentiation of apoptosis from necrosis by dynamic changes of reduced nicotinamide adenine dinucleotide fluorescence lifetime in live cells
HW Wang, V Gukassyan, CT Chen… - … of biomedical optics, 2008 - spiedigitallibrary.org
Direct monitoring of cell death (ie, apoptosis and necrosis) during or shortly after treatment is
desirable in all cancer therapies to determine the outcome. Further differentiation of …
desirable in all cancer therapies to determine the outcome. Further differentiation of …
Assessing responses to cancer therapy using molecular imaging
AA Neves, KM Brindle - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2006 - Elsevier
Tumor responses to therapy in the clinic are still evaluated primarily from non-invasive
imaging measurements of reductions in tumor size. This approach, however, lacks sensitivity …
imaging measurements of reductions in tumor size. This approach, however, lacks sensitivity …
Diffusion imaging: insight to cell status and cytoarchitecture
TL Chenevert, PC Sundgren… - Neuroimaging …, 2006 - neuroimaging.theclinics.com
Molecular imaging is commonly defined as the ability to localize and measure biologic
processes on the cellular and molecular level in the living organism. An imaging probe that …
processes on the cellular and molecular level in the living organism. An imaging probe that …
Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy
CJ Galbán, B Ma, D Malyarenko, MD Pickles, K Heist… - PloS one, 2015 - journals.plos.org
Purpose To evaluate diffusion weighted MRI (DW-MR) as a response metric for assessment
of neoadjuvant chemotherapy (NAC) in patients with primary breast cancer using …
of neoadjuvant chemotherapy (NAC) in patients with primary breast cancer using …